Orlistat in obese type II diabetics
391 obese type II diabetic patients were recruited to a randomised, double-bind, placebo-controlled trial of orlistat versus placebo.
Patients were clinically stable on sulphonylurea tablet treatment.
References:
- 1) Hollander, PA, Elbein, SC, Hirsch, IB et al. Role of orlistat in the treatment of obese patients with type 2 diabetes. Diabetes Care, 1998, 21, 1288-94.
Related pages
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page